Episode 1541: Bridget Phetasy
Bridget Phetasy: COVID Misinformation and Culture War Commentary
TL;DR: Rogan and Phetasy promote the false claim that hydroxychloroquine was “proven to be very effective” for COVID-19, three months after the FDA revoked its emergency use authorization due to lack of efficacy and safety concerns.
Bridget Phetasy is a writer, comedian, and cultural commentator who contributes to The Spectator, Quillette, and The New York Times. While much of this three-hour episode covers comedy, personal stories, and media criticism, it includes significant COVID-19 medical misinformation.
Hydroxychloroquine Misinformation
Early in the episode, Rogan and Phetasy discuss hydroxychloroquine (HCQ) as a COVID-19 treatment. Key claims made during the conversation:
“All these motherfuckers here are talking shit about it… you couldn’t get it anywhere on the west side of L.A., every rich person in L.A. went out and bought it.”
A doctor is referenced saying “people are not taking it because they hate Trump” and that it “has been proven to be very effective in the early, especially early” stages.
What the evidence says:
-
FDA (June 15, 2020): The FDA revoked the emergency use authorization for hydroxychloroquine three months before this episode aired, citing that it was “unlikely to be effective” and posed cardiac risks.
-
NIH ORCHID Trial (2020): The RECOVERY trial and ORCHID trial both found no benefit from hydroxychloroquine in hospitalized COVID-19 patients.
-
Nature Communications Meta-Analysis (2021): A meta-analysis of randomized trials found hydroxychloroquine was associated with increased mortality and provided no clinical benefit.
-
Multiple Systematic Reviews (2020): By August 2020, systematic reviews had already concluded HCQ had no benefit in treating mild to moderate COVID-19.
Why it matters
This claim was not just wrong — it was dangerously wrong. By September 2020, the scientific evidence was clear that hydroxychloroquine did not work for COVID-19 and carried cardiac risks. Framing refusal to use HCQ as political (“people are not taking it because they hate Trump”) discouraged listeners from following evidence-based medicine.
Joe Rogan’s Role
Rogan does not challenge the hydroxychloroquine claims. Instead, he participates in framing HCQ skepticism as politically motivated rather than scientifically grounded. This is part of a broader pattern during 2020-2021 where Rogan repeatedly promoted unproven COVID treatments to his audience of millions.
The framing that “rich people” were secretly buying HCQ while “talking shit about it” publicly reinforces a conspiratorial narrative that the medical establishment was hiding effective treatments for political reasons.
Media and Political Commentary
The episode contains extensive media criticism, including claims that:
- Mainstream media is “overwhelmingly liberal” and engages in “gaslighting” about protests and riots
- The media “red pilled America” through biased coverage
- Discussion of “the breakdown of society” and “the end of the empire”
While media criticism is legitimate, several claims cross into conspiratorial territory by attributing coordinated malicious intent rather than acknowledging the complexity of media bias. The conversation references Russian troll farm operations (which is well-documented) but also veers into unsubstantiated theories about institutional coordination.
Context and Nuance
Not everything in this episode is problematic. The conversation covers many harmless topics including:
- Comedy and comedian stories (Joey Diaz, Dave Chappelle, Colin Quinn)
- Personal stories about addiction recovery and therapy
- Discussion of meditation and breathing exercises
- Turning 40 and personal growth
However, the hydroxychloroquine misinformation is particularly concerning because it was stated as established fact at a time when the FDA had already determined the drug was ineffective for COVID-19.
Sources
- FDA Revokes EUA for Hydroxychloroquine (June 15, 2020)
- NIH: Hydroxychloroquine Does Not Benefit Hospitalized COVID-19 Patients
- NEJM: Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- Nature Communications: Meta-Analysis of Randomized Trials
- PMC: No Benefit of HCQ - Systematic Review
- FDA Caution Against HCQ Use Outside Hospital